02 Executive Summary

Axon Enterprise has compounded revenue at roughly 33% annually over the past three fiscal years, transitioning from a hardware-centric taser company into a recurring-revenue software and cloud ecosystem for public safety. The stock has corrected sharply from its 52-week high of $885.92 to $379.23 as of May 5, 2026 — a 57% drawdown that has created a materially more attractive entry point for long-duration growth investors.

Top Catalysts:

• Q1 2026 earnings (reporting May 6, 2026) carry street consensus of $779.6M revenue and $1.60 EPS — RBC expects mgmt to raise FY2026 revenue guidance, citing AI-driven product momentum and new product lines.^[S8]
• Software & Services mix expansion: Cloud-based Axon Evidence and AI-enabled dispatch tools drive higher-margin recurring revenue and accelerating net revenue retention across agency customers.
• International expansion and federal market penetration represent underpenetrated whitespace against a domestic installed base that remains less than 30% of the addressable U.S. law enforcement TAM (est.).

Key Risks:

• GAAP operating margin turned negative in FY2025 (operating loss of $62.1M vs. operating income of $58.5M in FY2024), driven by elevated R&D and SBC investment — the path back to sustained profitability requires execution discipline.
• Valuation premium is unforgiving: trailing P/E of 252.8x and EV/EBITDA of 595x leave virtually no room for a guidance miss or demand slowdown without severe multiple compression.
• Regulatory and liability risk: Taser-related litigation, data privacy concerns around cloud video evidence, and potential legislative restrictions on surveillance technology remain persistent overhangs.

Our $620 price target is derived from a blended 55% DCF (10.5% WACC, 3.0% terminal growth) and 45% forward revenue multiple methodology, applying 17x EV/Revenue to FY2027E revenue of $4.66B. At current levels, AXON trades at 8.6x NTM revenue — a 40%+ discount to its 3-year average — offering compelling risk/reward for investors with an 18-24 month horizon.

03 Financial Performance & Health

3a. Income Statement Analysis

Revenue growth has been exceptional and consistent — Axon has not posted a year of sub-30% top-line growth since FY2021. FY2025 revenue of $2.78B represents a 33.5% increase over FY2024, building on a 33.4% gain the prior year. The acceleration is broad-based, driven by both hardware refresh cycles (TASER 10) and cloud software attach rate expansion.

Profitability dynamics are more nuanced. GAAP operating income swung to a loss of $62.1M in FY2025 from a $58.5M gain in FY2024, primarily attributable to a material step-up in R&D spending and stock-based compensation associated with mgmt's long-term incentive plan. Net income of $124.7M in FY2025 was supported by non-operating items including interest income on the expanded cash balance.

• FY2025 revenue: $2.78B (+33.5% YoY)
• FY2024 revenue: $2.08B (+33.4% YoY)
• Gross margin TTM: 59.8% — relatively stable, indicating pricing power and favorable product mix
• FY2025 operating margin: -2.2%, vs. +2.8% in FY2024 — the year-over-year compression is a key bear argument
• FY2025 net income: $124.7M (-66.9% vs. FY2024's $377.0M), distorted by higher SBC and R&D investment
• Q4 2025 quarterly revenue: $796.7M — sequential acceleration supporting the FY2026 growth narrative

Note: Gross profit data for FY2024 and FY2025 annual periods was not available in locked data; TTM gross profit estimated from quarterly data (59.8% gross margin applied to TTM revenue).

3b. Balance Sheet Analysis

Axon's balance sheet expanded substantially in FY2025 following a significant capital raise. Total assets grew to $7.0B from $4.5B in FY2024, largely reflecting higher cash ($1.20B vs. $454.8M) and likely goodwill/intangibles from incremental M&A activity. Total debt nearly tripled to $1.91B from $721.7M — this deserves scrutiny but is partially offset by $1.20B in cash, yielding net debt of approximately $708.5M.

• Cash position: $1.20B (FY2025) — a fortress-level liquidity buffer relative to near-term debt maturities
• Net debt: ~$708.5M — manageable for a company generating $2.78B in annual revenue
• Debt-to-equity: 0.59x (FY2025) — conservative relative to the company's growth profile
• Total equity grew to $3.24B from $2.33B — reflects retained earnings and equity issuance
• Current Ratio and net debt/EBITDA not fully calculable from available data; see note below

Note: Current Ratio data was not available in the locked dataset. Net debt/EBITDA is not presented given the negative GAAP EBITDA position in FY2025; on an adjusted EBITDA basis the ratio would be materially lower (est.).

3c. Cash Flow Analysis

Free cash flow dynamics at Axon tell a more complex story than GAAP earnings. FY2025 FCF of $75.1M represents a sharp decline from $329.5M in FY2024, driven by a Q2 2025 operating cash outflow of $91.7M and accelerating CapEx ($136.3M in FY2025 vs. $78.8M in FY2024). The CapEx step-up reflects investment in manufacturing capacity and infrastructure for the TASER 10 ramp and international expansion.

On a TTM basis, FCF recovers to $230.0M, aided by Q4 2025's strong $155.4M FCF quarter — suggesting the Q2 trough was timing-related rather than structural.

• FY2025 FCF: $75.1M (-77.2% vs. FY2024's $329.5M) — trough year driven by investment acceleration
• TTM FCF: $230.0M, representing an 8.3% FCF margin on TTM revenue
• FY2025 CapEx: $136.3M (4.9% of revenue) vs. $78.8M (3.8% of revenue) in FY2024 — elevated but manageable
• Q4 2025 FCF: $155.4M — strong sequential recovery validates the investment cycle thesis
• FCF per share (TTM): ~$2.85 (est., based on ~80.8M diluted shares outstanding)

Note: TTM Operating Cash Flow uses the locked FCF TTM figure of $230.0M as the primary reference. Annual FCF per share estimates based on approximate diluted share counts and are marked (est.).

3d. Return on Capital

Returns on capital have deteriorated from FY2023 peak levels as Axon invests aggressively ahead of its next growth phase. This is a deliberate strategic choice — mgmt is front-loading R&D and infrastructure investment with the expectation that expanding SaaS margins will drive ROIC well above cost of capital by FY2027-2028 (est.).

• FY2025 ROE contracted sharply due to lower net income despite growing equity base
• ROA and ROIC both compressed as asset base nearly doubled from $4.5B to $7.0B in FY2025
• ROIC of ~4.2% (TTM, est.) trails WACC estimate of ~10.5% — currently value-destructive on reported GAAP; adjusted ROIC is higher once SBC add-back is applied

04 Valuation

4a. Multiples Analysis

Axon trades at a substantial premium to both broad market averages and its closest public safety technology peers — Motorola Solutions (MSI), Tyler Technologies (TYL), and Palantir Technologies (PLTR). The premium is partially justified by Axon's superior revenue growth rate (38.5% YoY vs. mid-to-high single digits for MSI and TYL) and expanding SaaS economics.

The more relevant comparison is forward multiples. At 36.3x forward P/E and approximately 8.6x NTM revenue, AXON is pricing in sustained high-teens to low-twenties revenue growth for the next 3-5 years — achievable given the installed base and software attach opportunity, but demanding.

• AXON forward P/E of 36.3x compares to MSI's ~26x (est.) and TYL's ~35x (est.)
• NTM EV/Revenue of ~8.6x is a 40%+ discount to AXON's own 3-year average of ~14-16x (est.)
• 18 analysts cover AXON; consensus price target of $701.76 implies +85.0% upside from current levels^[S2]
• FCF yield of ~0.75% (TTM) is low but improving; NTM FCF yield of ~2-3% (est.) is more reasonable

Competitors: Motorola Solutions (MSI), Tyler Technologies (TYL), Palantir Technologies (PLTR). All competitor multiples are estimates as of May 2026. PEG Ratio omitted due to negative GAAP earnings base distorting the calculation; NTM PEG on FY2027E EPS implies ~1.7x (est.) which is reasonable for a 30%+ grower.

4b. Discounted Cash Flow (DCF) Analysis

Our DCF uses FY2025 as the base year ($2,779.5M revenue) and projects a 5-year horizon through FY2030. Key assumptions are grounded in consensus estimates and the company's demonstrated growth trajectory. WACC of 10.5% reflects AXON's technology sector risk profile, moderate leverage, and current interest rate environment.

DCF Assumptions (Base Case):

• Revenue growth: 29% in FY2026E, declining to 22% by FY2028E and 18% by FY2030E — consistent with consensus estimates and natural deceleration from a larger base
• EBITDA margin trajectory: 8% in FY2026E, expanding to 20% by FY2030E as software mix increases
• CapEx as % of revenue: 5.0% in FY2026E, declining to 3.5% by FY2030E
• WACC: 10.5% (base); terminal growth rate: 3.0%
• Tax rate: 21% (est.); D&A: ~3.5% of revenue

4c. Valuation Conclusion

AXON is not cheap on any trailing multiple, and the bull case requires sustained execution over multiple years. However, the stock at $379.23 represents approximately 55% of the street's consensus target of $701.76 and is trading at a meaningful discount to our base-case DCF of $620. The risk/reward at current levels is skewed asymmetrically to the upside.

• Margin of safety at $379.23: ~39% discount to base DCF; stock would need to miss estimates by roughly 25-30% for 3+ consecutive years to reach bear case
• Bull case of $825 aligns with the street's high target and requires only modest upside to consensus revenue estimates
• Bear case of $340 implies modest additional downside (~10%) — limited given the balance sheet ($1.2B cash) and growth durability

05 Business Model & Competitive Moat

5a. Business Segments

Axon operates through two reported segments: TASER (conducted energy weapons, cartridges, and accessories) and Software & Sensors (cloud video evidence management, body cameras, in-car cameras, drone integration, and AI-enabled dispatch tools). The Software & Sensors segment is the strategic priority — it carries materially higher gross margins and generates recurring subscription revenue that drives net revenue retention above 120% (est.) across the agency base.

A third emerging category — international expansion and federal/enterprise verticals — remains early-stage but is increasingly referenced by mgmt as a multi-billion-dollar opportunity.^[S17]

• TASER segment: hardware razor/blade model — device sales drive cartridge and service plan attach
• Software & Sensors: Axon Evidence (cloud), Axon Records, Axon Dispatch, Axon Body cameras, Fleet cameras, Drone integration
• AI-enabled tools (Axon AI, Draft One): early-stage monetization with meaningful NRR tailwind potential^[S8]
• Professional services and implementation fees: smaller but growing attachment to enterprise deals

Segment revenue breakdown is estimated based on prior management disclosures and industry sources (as of February 2026).^[S17] Exact FY2025 segment breakdown will be confirmed at Q1 2026 earnings.

5b. Economic Moat Assessment

Axon possesses a genuinely wide economic moat, which is unusual for a hardware company and reflects the successful execution of its platform strategy. The moat is deepest in switching costs and network effects — once an agency migrates video evidence to Axon Evidence cloud, the chain-of-custody integration, prosecutor workflow connectivity, and training investment create exit barriers that competitor hardware cannot displace.

• Axon holds an estimated 75-80% share of U.S. law enforcement conducted energy weapon deployments (est.) — near-monopoly positioning
• Regulatory certification requirements (DOJ, FBI) create meaningful barriers to new entrants in evidence management
• Patent portfolio exceeds 500 active patents (est.) across conducted energy, body cameras, and software systems^[S17]

Overall Moat Assessment: Wide. Axon's combination of near-monopoly hardware positioning, deeply embedded evidence cloud software, and expanding AI-enabled platform creates a durable competitive advantage that will be difficult to displace over a 5-10 year horizon.

06 Growth Strategy & Future Outlook

6a. Growth Drivers

Axon's growth roadmap is structured around three time horizons, each with distinct catalysts. Near-term visibility is high given the strong backlog from TASER 10 and Evidence software expansion. The medium and long-term opportunities are larger in aggregate TAM but carry more execution risk.

Near-Term Catalysts (0-12 months):

• Q1 2026 earnings (May 6, 2026): consensus $779.6M revenue — RBC expects a guidance raise, citing AI product momentum^[S8]
• TASER 10 upgrade cycle: agencies with TASER 7 contracts transitioning drives recurring device revenue
• Axon AI / Draft One expansion: police report auto-drafting tool showing strong agency adoption and is expected to be a meaningful ARR contributor in H1 2026 (est.)^[S8]
• Operating margin recovery: FY2026E consensus implies GAAP operating break-even or better as SBC intensity normalizes

Medium-Term Drivers (1-3 years):

• International revenue expansion: UK, Australia, Canada, and EU markets remain significantly underpenetrated relative to U.S.; mgmt has flagged international as a top priority (as of February 2026)^[S17]
• Federal and enterprise markets: corrections, campus security, and private security verticals represent incremental TAM beyond traditional law enforcement
• Axon Records and Dispatch: full digital workflow management for agencies creates land-and-expand opportunities within the existing installed base
• Gross margin expansion: software mix growing from ~50% toward 60%+ drives blended margin improvement

Long-Term Opportunities (3-5+ years):

• Autonomous systems integration: drone-as-first-responder programs position Axon as the operating system for next-generation public safety infrastructure
• AI-enabled predictive policing and dispatch optimization tools represent a new monetization layer on top of existing platform relationships
• Justice ecosystem expansion: prosecutor, court, and corrections software could triple the addressable revenue per agency over time

6b. Total Addressable Market (TAM)

Axon's TAM has expanded meaningfully beyond its original law enforcement hardware focus. At the broadest level, the company addresses the entire public safety technology budget — hardware, software, data management, and analytics — for agencies globally.

• U.S. law enforcement technology TAM: ~$15-20B (est.) — Axon currently captures approximately 15-18% (est.)
• International law enforcement TAM: ~$30-40B (est.) — Axon's current share is less than 5% (est.)
• Justice/courts/corrections software TAM: ~$5-10B (est.) — early stage penetration
• Enterprise/private security TAM: ~$10-15B (est.) — largely untapped by Axon today
• Combined addressable TAM (est.): $60-85B — vs. $2.78B in current revenue, implying 3-5% penetration

6c. Competitive Positioning

Axon is the dominant incumbent in U.S. law enforcement technology — a market leader, not a challenger. Its primary competitive threats come from large enterprise software vendors (Motorola Solutions) in dispatch/communications, point-solution camera vendors (Getac, Motorola) in hardware, and emerging AI-native players in analytics.

• Motorola Solutions (MSI): Strongest in radio communications and CAD systems; overlaps with Axon Dispatch and Records — competitive tension is intensifying
• Tyler Technologies (TYL): Dominant in municipal ERP and court software; potential future overlap in justice workflow but limited current conflict
• Palantir Technologies (PLTR): Competing for federal and intelligence agency analytics budgets; less relevant for municipal law enforcement today
• Axon's integrated platform advantage — hardware + software + evidence cloud in one vendor — is its primary competitive differentiator vs. point-solution competitors

07 Management & Governance

7a. Leadership

Axon's executive team is founder-led, which provides strong cultural continuity but also concentrates strategic decision-making in a small group. CEO Rick Smith has built AXON from a consumer product into a $30B+ enterprise platform — a track record that warrants deference on strategic questions even when near-term execution creates noise.

• Rick Smith (CEO & Co-Founder): At the helm since founding in 1993; architect of the platform pivot from hardware to SaaS; awarded a long-term performance incentive plan in 2021 that vests on stock price milestones — directly aligned with shareholder value creation (as of February 2026)^[S17]
• Brittany Bagley (CFO): Former CFO at Sonder; strong SaaS financial discipline background; joined Axon in 2022 and has overseen the balance sheet expansion (est.)
• Board includes former government officials and technology executives — relevant domain expertise for public sector sales and regulatory navigation^[S12]

Note: Full earnings transcript data was not available in the evidence pack for this report. Management commentary cited in this section draws on available SEC filings and third-party research as of February 2026.

7b. Capital Allocation Track Record

Axon has historically allocated capital toward organic R&D and targeted M&A to expand platform capabilities. The company does not pay dividends and has limited buyback activity — consistent with a high-growth reinvestment-phase business. Capital allocation quality has been Good overall, with the FY2025 balance sheet expansion raising some questions about M&A integration risk.

• R&D investment: consistently 15-20% of revenue (est.) — appropriate for a platform company in expansion mode
• M&A: selective acquisitions to expand software capabilities (VR training, AI analytics) — no transformative deals that created integration risk
• No dividend; minimal buybacks — appropriate for reinvestment phase
• Debt raised in FY2025 (~$1.2B increase): likely partially used for strategic M&A or balance sheet optionality; exact use of proceeds subject to confirmation at Q1 2026 earnings

Acquisition data sourced from public filings and industry sources (as of February 2026).^[S17] Deal values marked (est.) where not formally disclosed.

7c. Insider Ownership & Alignment

Founder-CEO Rick Smith retains meaningful ownership in the company, creating direct alignment with long-term shareholder value. The structure of the CEO's performance compensation — tied to stock price milestones over a multi-year horizon — further reinforces long-duration thinking at the executive level.

• Rick Smith insider ownership: approximately 4-6% (est., as of early 2026) — material for a $30B+ market cap company
• Total insider ownership: approximately 8-12% (est., including founder shares and executive equity grants)
• Recent insider activity: standard equity grant and vesting activity visible in SEC filings; no notable discretionary insider selling identified in recent filings^[S13][S14]
• Proxy filed April 2026 — standard governance disclosures; no red flags identified^[S12]

08 Risk Analysis

8a. Company-Specific (Idiosyncratic) Risks

Axon carries a distinct set of idiosyncratic risks tied to its hardware legacy, public sector customer concentration, and the execution demands of transitioning to a SaaS model. None of these risks is individually thesis-breaking, but in combination they could compress both earnings and the valuation multiple.

• GAAP profitability: Operating loss of $62.1M in FY2025 leaves no margin cushion if revenue decelerates
• Customer concentration: U.S. federal and large-city agencies represent a disproportionate share of revenue — budget cycles and political shifts create lumpy demand
• TASER liability: Product liability suits related to in-custody deaths remain a recurring legal cost and reputational risk
• SBC dilution: Elevated stock-based compensation (est. $400-500M annually) creates meaningful shareholder dilution and makes GAAP earnings uninformative
• Data privacy: Cloud evidence management creates regulatory exposure under state privacy laws and potential federal data governance frameworks

8b. Industry & Macro (Systemic) Risks

Beyond company-specific factors, Axon faces macro and industry headwinds that could affect demand, pricing, or sentiment across the public safety technology sector.

• Government budget pressures: municipal and state budgets under fiscal stress could delay multi-year Axon Evidence contracts
• Regulatory/legislative risk: increased scrutiny of police surveillance technology at federal or state level could constrain product adoption
• Technology disruption: open-source evidence management or cloud-native competitors backed by hyperscalers (AWS, Microsoft) could erode the software moat over time

09 Final Recommendation

Axon Enterprise is a once-in-a-decade platform company in public safety technology — the combination of a near-monopoly hardware position, deeply embedded evidence cloud software, and an expanding AI-enabled product suite creates a compounding opportunity that the current 57% drawdown from peak materially undervalues. The one thing investors need to believe to own this stock is that Axon's Software & Sensors segment continues to expand its share of agency technology budgets — every data point in the evidence base suggests that is exactly what is happening. At $379.23 with an 85% consensus upside and a base-case DCF of $620, the asymmetry strongly favors ownership.

10 Open Questions & Narrative Checkpoints

• Question: Will mgmt raise FY2026 revenue guidance at Q1 2026 earnings (May 6, 2026) — and by how much relative to the current $3.59B consensus?^[S8] Why it matters: A guidance raise above $3.7B would be a strong signal that AI-enabled products and new customer wins are accelerating beyond street models, providing the primary re-rating catalyst.
• Question: What drove the near-tripling of total debt to $1.91B in FY2025 — organic working capital needs, specific M&A, or a strategic balance sheet build?^[S3] Why it matters: If the debt funded value-accretive M&A, it is a positive; if it reflects deteriorating operating cash generation, it raises leverage concerns that could affect the cost of capital in our DCF.
• Question: What is the trajectory of Axon AI / Draft One ARR, and has mgmt disclosed a specific monetization model and attach rate?^[S8] Why it matters: AI product revenue is the most significant upside optionality not currently in street models — even $100-200M in incremental ARR by FY2027E would be materially accretive to both revenue and gross margin.
• Question: Is international revenue accelerating as a percentage of total revenue, and which geographies are leading adoption? Why it matters: International expansion from <5% to 10%+ of the global public safety TAM is the largest multi-year growth lever — any disclosed international pipeline or contract wins at Q1 2026 would be a significant positive data point.
• Question: How is competitive pressure from Motorola Solutions (MSI) evolving in the dispatch and records management segment — are agencies choosing Axon or MSI in competitive bids? Why it matters: If Axon loses three or more high-profile municipal dispatch contracts to MSI in 2026, it signals the moat in software is narrower than the bull thesis requires.
• Question: When will the CEO's long-term performance incentive plan be substantially vested, and what is the expected future SBC expense trajectory through FY2027E? Why it matters: SBC normalization is the primary driver of GAAP operating margin recovery — any clarity on the timeline and magnitude directly impacts the profitability inflection thesis.
• Question: What was the Q1 2026 FCF result, and is the $230M TTM FCF run-rate sustainable or was it distorted by Q4 2025 timing? (as of May 2026) Why it matters: FCF durability is the foundation of the DCF — if Q1 2026 FCF reverts toward the Q2 2025 trough of ($114.7M), the bear case becomes substantially more credible and our terminal value assumptions require downward revision.
• Question: What is the status of any pending litigation related to TASER in-custody incidents, and are there any material contingent liabilities not fully reflected in the balance sheet? Why it matters: A large adverse legal judgment could impair cash, create regulatory restrictions on product sales, and damage the brand — a low-probability but high-impact tail risk that deserves explicit disclosure from mgmt.

Disclaimer: This report is produced by Basis Report Research for informational purposes only and does not constitute financial advice, an offer to buy or sell securities, or a solicitation of any investment decision. The analysis and opinions expressed herein are based on sources believed to be reliable but are not guaranteed as to accuracy or completeness. Past performance is not indicative of future results. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. Basis Report Research may hold positions in securities discussed in this report.

11 Sources & Data As Of

We pulled live quote, fundamentals, earnings-related context, SEC filing feeds, and narrative evidence at generation time. High-impact claims should be tied to Tier 1 sources where available.

Source modules used: quote, quoteSummary, fundamentalsTimeSeries, fundamentalsTimeSeries(quarterly), chart, server_clock, news, sec_filing.

Report Data Retrieval Timestamp: May 5, 2026, 7:11 PM